Form 4 for IMDX Insight Molecular Diagnostics Inc.

Accepted 2025-02-11 00:00:00 ET · period of report 2025-02-07 · accession 0001493152-25-005942 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
I	2025-02-11	2025-02-07	IMDX	SMITH PATRICK W	10%	J - Other	$2.05	+385.8K	3.26M	+13%	+$790.9K
I	2025-02-11	2025-02-07	IMDX	SMITH PATRICK W	10%	P - Purchase	$2.05	+1.08M	2.87M	+60%	+$2.21M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, no par value	2025-02-07	J	A	385,814	$2.05	3,258,485	I See footnote	—	—	(F3) Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a registered direct offering pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto. (F2) The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.
2	Common	Common Stock, no par value	2025-02-07	P	A	1,077,600	$2.05	2,872,671	I See footnote	—	—	(F1) Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private placement pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto. (F2) The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.